Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis

Gastroenterology

Volumn 153, Issue 1, 2017, Pages 49-52.e5

  Saadoun, David ^a,b,c,d   Pol, Stanislas ^e   Ferfar, Yasmina ^a,b,c,d   Alric, Laurent ^f   Hezode, Christophe ^g   Si Ahmed, Si Nafa ^h   de Saint Martin, Luc ⁱ   Comarmond, Cloé ^a,b,c,d   Bouyer, Anne Sophie ^a,b,c,d   Musset, Lucile ^d   Poynard, Thierry ^d   Resche Rigon, Matthieu ^j   Cacoub, Patrice ^a,b,c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b Unité Médicale de Recherche_S 959 ^*  (France)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f CHU PURPAN   (France)

^g HENRI MONDOR HOSPITAL   (France)

^h Department of Rheumatology   (France)

ⁱ BREST UNIVERSITY HOSPITAL   (France)

^j SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

Autoimmunity; Cryoglobulinemia Vasculitis; DAA; Treg Cell

Indexed keywords

ALANINE AMINOTRANSFERASE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT COMPONENT C4; CRYOGLOBULIN; DACLATASVIR; IMMUNOGLOBULIN M; INTERLEUKIN 21; RHEUMATOID FACTOR; SOFOSBUVIR; VIRUS RNA; ANTIVIRUS AGENT; BMS-790052; CXCR5 PROTEIN, HUMAN; IMIDAZOLE DERIVATIVE; INTERLEUKIN DERIVATIVE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; BLOOD BIOCHEMISTRY; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CRYOGLOBULINEMIA; CRYOGLOBULINEMIA VASCULITIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVENT FREE SURVIVAL; FATIGUE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN CELL; INSOMNIA; MALE; MEMORY CELL; MIDDLE AGED; MULTICENTER STUDY; NAUSEA; OPEN STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; RELAPSE; REMISSION; SUSTAINED VIROLOGIC RESPONSE; SYMPTOMATOLOGY; TH17 CELL; TREATMENT DURATION; TREATMENT RESPONSE; VASCULITIS; VERTIGO; VIRAL CLEARANCE; B LYMPHOCYTE; BLOOD; CD4+ T LYMPHOCYTE; CHEMISTRY; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPLICATION; LYMPHOCYTE COUNT; METABOLISM; VIROLOGY;

ANTIVIRAL AGENTS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CRYOGLOBULINEMIA; CRYOGLOBULINS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C; HUMANS; IMIDAZOLES; IMMUNOGLOBULIN M; INTERLEUKINS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, COMPLEMENT 3D; RECEPTORS, CXCR5; SOFOSBUVIR; SUSTAINED VIROLOGIC RESPONSE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; VASCULITIS;

EID: 85020932922     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.03.006     Document Type: Article

References (21)

1. Ramos-Casals, M., et al. Lancet 379 (2012), 348–360.
2. Cacoub, P., et al. Am J Med 128 (2015), 950–955.
3. Dammacco, F., et al. N Engl J Med 369 (2013), 1035–1045.
4. Ferri, C., et al. Semin Arthritis Rheum 33 (2004), 355–374.
5. Saadoun, D., et al. Curr Opin Rheumatol 20 (2008), 23–28.
6. Saadoun, D., et al. N Engl J Med 365 (2011), 2067–2077.
7. De Vita, S., et al. Arthritis Rheum 64 (2012), 843–853.
8. Saadoun, D., et al. Ann Rheum Dis 75 (2016), 1777–1782.
9. Gragnani, L., et al. Hepatology 64 (2016), 1473–1482.
10. Sise, M.E., et al. Hepatology 63 (2016), 408–417.
11. Bonacci, M., et al. Clin Gastroenterol Hepatol 15 (2017), 575–583.
12. Sollima, S., et al. Rheumatology (Oxford) 55 (2016), 2084–2085.
13. Landau, D.A., et al. Arthritis Rheum 58 (2008), 604–611.
14. Arcaini, L., et al. Blood 128 (2016), 2527–2532.
15. Saadoun, D., et al. Ann Rheum Dis 73 (2014), 831–837.
16. Laperche, S., et al. J Clin Microbiol 44 (2006), 614–616.
17. Musset, L., et al. Clin Chem 38 (1992), 798–802.
18. Brouet, J.C., et al. Am J Med 57 (1974), 775–788.
19. The French METAVIR Cooperative Study Group. Hepatology 20 (1994), 15–20.
20. Bastyr, E.J., et al. Clin Ther 27 (2005), 1278–1294.
21. Luqmani, R.A., et al. QJM 87 (1994), 671–678.